MENU
+Compare
AORT
Stock ticker: NYSE
AS OF
Dec 26, 04:33 PM (EDT)
Price
$46.48
Change
-$0.41 (-0.87%)
Capitalization
2.22B

AORT Artivion Forecast, Technical & Fundamental Analysis

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions... Show more

AORT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AORT with price predictions
Dec 24, 2025

AORT in upward trend: price rose above 50-day moving average on December 10, 2025

AORT moved above its 50-day moving average on December 10, 2025 date and that indicates a change from a downward trend to an upward trend. In of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 16, 2025. You may want to consider a long position or call options on AORT as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AORT just turned positive on December 17, 2025. Looking at past instances where AORT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AORT entered a downward trend on December 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.063) is normal, around the industry mean (63.841). P/E Ratio (0.000) is within average values for comparable stocks, (37.253). AORT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.634). AORT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (4.904) is also within normal values, averaging (36.935).

View a ticker or compare two or three
AORT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

AORT is expected to report earnings to fall 56.25% to 7 cents per share on February 12

Artivion AORT Stock Earnings Reports
Q4'25
Est.
$0.07
Q3'25
Beat
by $0.13
Q2'25
Beat
by $0.24
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.33
The last earnings report on November 06 showed earnings per share of 15 cents, beating the estimate of 2 cents. With 15.71K shares outstanding, the current market capitalization sits at 2.22B.
A.I.Advisor
published Dividends

AORT paid dividends on December 18, 2015

Artivion AORT Stock Dividends
А dividend of $0.03 per share was paid with a record date of December 18, 2015, and an ex-dividend date of December 09, 2015. Read more...
A.I. Advisor
published General Information

General Information

a provider of cryopreserved human tissue for vascular transplant applications

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1655 Roberts Boulevard North West
Phone
+1 770 419-3355
Employees
1500
Web
https://www.artivion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABLOX22.750.08
+0.35%
Alger Balanced I-2
FGHMX132.010.45
+0.34%
Fidelity Advisor Communication ServicesC
WOOSX17.130.03
+0.18%
JPMorgan SMID Cap Equity R6
AWPZX21.840.03
+0.14%
AB Sustainable International Thematic Z
PAIGX24.09-0.02
-0.08%
T. Rowe Price International Value Eq Adv

AORT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-0.61%
TCMD - AORT
43%
Loosely correlated
-0.58%
LMAT - AORT
42%
Loosely correlated
+0.44%
SONVY - AORT
42%
Loosely correlated
-0.13%
SYK - AORT
41%
Loosely correlated
-0.02%
VREX - AORT
40%
Loosely correlated
+0.66%
More

Groups containing AORT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-0.61%
Medical/Nursing Services
industry (213 stocks)
42%
Loosely correlated
+0.01%
Health Services
industry (403 stocks)
-7%
Poorly correlated
+0.00%